HS
HighVista Strategies’s Keros Therapeutics KROS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $702K | Buy |
52,618
+511
| +1% | +$6.82K | 0.26% | 115 |
|
|
2025
Q1 | $531K | Hold |
52,107
| – | – | 0.2% | 126 |
|
|
2024
Q4 | $825K | Hold |
52,107
| – | – | 0.31% | 109 |
|
|
2024
Q3 | $3.03M | Buy |
52,107
+12,899
| +33% | +$749K | 1.04% | 29 |
|
|
2024
Q2 | $1.79M | Hold |
39,208
| – | – | 0.65% | 49 |
|
|
2024
Q1 | $2.6M | Buy |
+39,208
| New | +$2.6M | 0.93% | 33 |
|
|
2023
Q1 | – | Sell |
-18,616
| Closed | -$894K | – | 123 |
|
|
2022
Q4 | $894K | Buy |
+18,616
| New | +$894K | 0.53% | 53 |
|
|
2022
Q3 | – | Sell |
-16,623
| Closed | -$459K | – | 122 |
|
|
2022
Q2 | $459K | Buy |
16,623
+583
| +4% | +$16.1K | 0.28% | 78 |
|
|
2022
Q1 | $872K | Buy |
+16,040
| New | +$872K | 0.55% | 49 |
|